De-escalation of Post-mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes

[1] Overgaard M(1997)Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med. 71 15-29

[2] Hansen PS(1999)Postoperative radiotherapy in high-risk postmenopausal breastcancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet undefined undefined-undefined

[3] Overgaard J(1997)Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med. undefined undefined-undefined

[4] Overgaard M(2016)Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update J Clin Oncol. undefined undefined-undefined

[5] Jensen M-B(2015)Internal mammary and medial supraclavicular irradiation in breast cancer N Engl J Med. undefined undefined-undefined

[6] Overgaard J(2015)Regional nodal irradiation in early-stage breast cancer N Engl J Med. undefined undefined-undefined

[7] Ragaz J(2014)Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Lancet undefined undefined-undefined

[8] Jackson SM(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med. undefined undefined-undefined

[9] Le N(2021)21-Gene assay to inform chemotherapy benefit in node-positive breast cancer N Engl J Med. undefined undefined-undefined

[10] Recht A(2018)Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer N Engl J Med. undefined undefined-undefined

[1] Overgaard M(1997)Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med. 71 15-29

[2] Hansen PS(1999)Postoperative radiotherapy in high-risk postmenopausal breastcancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet undefined undefined-undefined

[3] Overgaard J(1997)Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med. undefined undefined-undefined

[4] Overgaard M(2016)Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update J Clin Oncol. undefined undefined-undefined

[5] Jensen M-B(2015)Internal mammary and medial supraclavicular irradiation in breast cancer N Engl J Med. undefined undefined-undefined

[6] Overgaard J(2015)Regional nodal irradiation in early-stage breast cancer N Engl J Med. undefined undefined-undefined

[7] Ragaz J(2014)Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials Lancet undefined undefined-undefined

[8] Jackson SM(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med. undefined undefined-undefined

[9] Le N(2021)21-Gene assay to inform chemotherapy benefit in node-positive breast cancer N Engl J Med. undefined undefined-undefined

[10] Recht A(2018)Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer N Engl J Med. undefined undefined-undefined